BCL2 and breast carcinoma: Hence, in our research group employing a well-established protocol of virtual screening, in addition to combining docking and molecular dynamics simulations, were designed, synthesized, and assayed in vitro, two new compounds herein identified as 6 and 37, aimed to block the deregulated activity of GPER and Bcl-2 on two cell lines of breast cancer.